RxDoctor Payments Data

Matthew Needleman, MD

Clinical Cardiac Electrophysiology · Bethesda, MDNPI 1972583409

Payments from drug & device makers

What this record shows

8 manufacturers reported payments, led by Abbott at 55.0% of the total. Reporting peaked in 2023 at $2,700 and has fallen 94.2% since, to $157 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MD, where the typical reported total is $15,262.

$7,494in general payments, 2019–2025

Across 88 payments — averaging $85.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Medtronic$3K
  • Biosense Webster, Inc.$240
  • Cardiva Medical, Inc.$183
  • Bardy Diagnostics, Inc.$132
  • Acutus Medical, Inc.$52
  • plus $46 from 2 others

What the payments were for

  • Travel & lodging$3,85951%
  • Food & beverage$3,63649%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott28$4,123
Medtronic(2 entities)44$2,719
Biosense Webster, Inc.4$240
Cardiva Medical, Inc.6$183
Bardy Diagnostics, Inc.2$132
Acutus Medical, Inc.1$52
Boston Scientific2$31
Stryker1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,494 in reported general payments places this provider in the 25th percentile of 63 clinical cardiac electrophysiology providers in Maryland.

See all clinical cardiac electrophysiology providers in Maryland

Medicare billing

Part B allowed, 2024
$1,533
Medicare patients
20
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MultaqDronedarone Hcl23$38,456
Ranolazine ErRanolazine11$703
Amiodarone Hcl16$440
Metoprolol Succinate16$248
Furosemide19$209
Metoprolol Tartrate19$184
Carvedilol14$154

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →